James D. Swift - Mar 1, 2023 Form 4 Insider Report for Pediatrix Medical Group, Inc. (MD)

Role
Chief Executive Officer
Signature
/s/ Mary Ann E. Moore, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Mar 1, 2023
Transactions value $
-$155,968
Form type
4
Date filed
3/3/2023, 04:01 PM
Previous filing
Nov 9, 2022
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Award $0 +49.8K +71.1% $0.00 120K Mar 1, 2023 Direct F1, F2
transaction MD Common Stock Tax liability -$156K -9.91K -8.28% $15.74 110K Mar 1, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on March 1, 2024, twenty-five percent (25%) of the restricted shares will vest on March 1, 2025 and fifty percent (50%) of the restricted shares will vest on March 1, 2026, subject to the terms of the Plan.
F2 Excludes 17,974 previously reported shares of restricted common stock granted to the reporting person pursuant to the Plan in connection with an annual equity award that were forfeited because the performance-based criteria were not achieved.
F3 Represents 9,909 restricted shares withheld for payment of taxes upon vesting of shares.